Delivery Order SPE2DR25D1205-SPE2DR26F1AD2
- Not listed
- The Defense Logistics Agency awarded a $8,630.28 delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units) on July 15, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count) valued at $9,053.16 under a firm fixed price contract structure. This non-set-aside award was issued on November 7, 2025, with an ultimate completion date of December 2, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.29 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $9,396.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Ofev 150 mg capsules (60-count units). The contract, which carries an ultimate completion date of February 2, 2026, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no set-aside designation. The pharmaceutical...
- The Defense Logistics Agency awarded a $25,851.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Ofev 100 mg capsules in a quantity of 60 units. This is a non-set-aside contract with a completion deadline of May 27, 2025, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $18,106.32 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units) with a firm fixed price arrangement. This non-set-aside, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of December 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to support federal medical procurement requirements. The order is scheduled for ultimate completion by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units). This firm fixed-price contract, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a $9,094.99 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Ofev 100 mg capsules (60-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 15, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's broader...
- The Defense Logistics Agency awarded a $8,630.28 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AD2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,396.81 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units) on January 16, 2026, with a completion date of February 9, 2026. This firm fixed-price order is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as the prime contractor on this delivery order, which is issued under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's comprehensive indefinite delivery contract with Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the prime IDC that enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The award demonstrates the contractor's ongoing role in fulfilling essential pharmaceutical needs for federal military treatment facilities and veteran healthcare systems through competitive, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 1/15/26 |